Sound Pharmaceuticals Invited To Present At The 16th Annual Needham & Company Healthcare Conference

Tuesday, April 4, 2017 Drug News
Email Print This Page Comment
Font : A-A+

SEATTLE, April 3, 2017 /PRNewswire/ -- Sound Pharmaceuticals, a private biopharmaceutical company, and leader in developing

novel drug treatments for the inner ear and brain, announced today that Jonathan Kil, MD, Co-Founder, Chief Executive Officer, and Chief Medical Officer has been invited to present at the 16th Annual Needham
& Company Healthcare Conference on Tuesday, April 4th at 1:40 pm EDT in New York, NY.

Dr. Kil will provide an update on the Company's R&D milestone achievements from the past year, along with the strategic objectives for its three neurotologic programs. SPI has four active Investigational New Drug applications with the FDA involving several indications including noise induced hearing loss, Meniere's disease, and chemotherapy and antibiotic induced ototoxicity. In addition, he will highlight some of the significant market opportunities within the field of hearing and balance, specifically, in the area of neurotology.

Needham & Company's 16th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors.

About Sound Pharmaceuticals

Sound Pharmaceuticals, Inc. (SPI) is a pioneer in neurotologic drug development aimed at treating sensorineural diseases of the inner ear. SPI is developing the first therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss and tinnitus including ototoxicity and Meniere's disease. Sensorineural hearing loss is the third largest disease and affects 50 million Americans. SPI is a privately held biotechnology company headquartered in Seattle, WA.

Contact:

Sound Pharmaceuticalsir@soundpharma.comwww.soundpharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sound-pharmaceuticals-invited-to-present-at-the-16th-annual-needham--company-healthcare-conference-300432325.html

SOURCE Sound Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook